Project Grant HT94252410784
Award Date
7/15/24
Completion Date
7/14/27
Dollars Obligated
$707K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
This $381,312.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research at the University of Massachusetts Medical School to determine the molecular etiology of and strategies to block pancreatic cancer cachexia. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Massachusetts Medical School is the awardee and will be conducting the research through its Grants and...
The federal Project Grant award, valued at $728,450.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research conducted by the Cold Spring Harbor Laboratory (CSHL) on the communication between cancer-associated fibroblasts and neurons, and how this interaction promotes the progression of pancreatic cancer. The award, which runs from July 1, 2025 to June 30, 2028, will enable CSHL to carry out advanced biomedical...
This federal Project Grant award, valued at $153,309.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the University of Massachusetts to model the spread of airborne pathogens through lung-on-a-chip technology. The research aims to transform healthcare for military service members and the broader public by developing innovative approaches to disease prevention, diagnosis, and treatment. The...
The Defense Health Agency awarded a $522,477 Project Grant to Boston Medical Center Corporation (BMC) under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to define genetic vulnerabilities in pancreatic neuroendocrine tumors that rely on the alternative lengthening of telomeres pathway. This 3-year project grant runs from August 1, 2023 to July 31, 2026. A sub-award of an unspecified amount was provided to the Trustees of Boston...
The University of Massachusetts Amherst was awarded a $557,247 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from February 1, 2023 to January 31, 2026 to develop intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The Military Medical Research and Development program supports innovative medical research with...
The University of Massachusetts Amherst will receive $570,810 through January 31, 2026 from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The funding will support the university's applied research efforts to transform health care for service members and the public through innovative...
This $602,550 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) supports adoptive cellular therapy research for pancreatic cancer. The awardee, the University of Nebraska Medical Center (UNMC), will conduct innovative biomedical research to develop novel therapeutic approaches, perform clinical trials, and provide technical expertise in this critical medical field. As a prominent academic research...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $5,712,429.00 to the University of Massachusetts Medical School to conduct research on "CRISPR-BASED ADIPOSE THERAPIES FOR ACCELERATED AGING IN IRRADIATED NONHUMAN PRIMATES." The award period runs from July 1, 2025 to June 30, 2028. The research aims to develop novel CRISPR-based therapies to address accelerated aging in...
This Project Grant award, totaling $757,212.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Massachusetts Medical School Grants and Contracts Administration Division for the "PRECLINICAL DEVELOPMENT OF AN ORAL NANOBODY PROPHYLACTIC TO PREVENT DIARRHEAL DISEASE." The funding will support research and development of an oral nanobody-based therapeutic to prevent diarrheal disease, with an award...
The U.S. Department of Defense's Defense Health Agency awarded a $384,000 Project Grant to the Cold Spring Harbor Laboratory (CSHL) to study the impact of recurrent acute pancreatitis on macrophage heterogeneity and function. This grant, awarded under the Military Medical Research and Development program (CFDA 12.420), will fund research aimed at improving the health and care of military service members, veterans, and their families. The grant has a performance period from February 1, 2024 to...